Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.

● The earnings growth currently anticipated by analysts for the coming years is particularly strong.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company has a low valuation given the cash flows generated by its activity.

● The company is one of the best yield companies with high dividend expectations.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● In relation to the value of its tangible assets, the company's valuation appears relatively high.

● Over the past twelve months, analysts' opinions have been revised negatively.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.